Account Management LLC Invests $1.33 Million in Teladoc (TDOC)
Account Management LLC bought a new stake in Teladoc (NYSE:TDOC) during the 1st quarter, HoldingsChannel reports. The fund bought 32,902 shares of the health services provider’s stock, valued at approximately $1,326,000. Teladoc comprises 1.2% of Account Management LLC’s investment portfolio, making the stock its 16th largest holding.
Several other institutional investors and hedge funds have also recently made changes to their positions in TDOC. SG Americas Securities LLC bought a new position in Teladoc during the 4th quarter worth about $101,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Teladoc by 68.8% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,874 shares of the health services provider’s stock worth $116,000 after purchasing an additional 1,171 shares in the last quarter. Montag A & Associates Inc. acquired a new stake in Teladoc in the 4th quarter worth approximately $200,000. Xact Kapitalforvaltning AB acquired a new stake in Teladoc in the 4th quarter worth approximately $203,000. Finally, Buckley Wealth Management LLC acquired a new stake in Teladoc in the 4th quarter worth approximately $221,000.
Shares of NYSE:TDOC opened at $49.45 on Thursday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 4.15 and a current ratio of 4.15. The stock has a market cap of $3.02 billion, a price-to-earnings ratio of -29.97 and a beta of 0.35. Teladoc has a 1 year low of $49.10 and a 1 year high of $49.75.
A number of research firms recently commented on TDOC. Craig Hallum set a $39.00 target price on shares of Teladoc and gave the stock a “hold” rating in a research note on Wednesday, May 2nd. Jefferies Group began coverage on shares of Teladoc in a research note on Friday, January 26th. They issued a “buy” rating and a $40.00 target price for the company. Deutsche Bank cut shares of Teladoc from a “buy” rating to a “hold” rating and set a $45.00 target price for the company. in a research note on Thursday, March 15th. Canaccord Genuity lifted their target price on shares of Teladoc from $43.00 to $45.00 and gave the stock a “buy” rating in a research note on Wednesday, February 28th. Finally, ValuEngine upgraded shares of Teladoc from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, May 2nd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the stock. Teladoc currently has a consensus rating of “Buy” and a consensus target price of $42.67.
In other Teladoc news, SVP Andrew Turitz sold 19,245 shares of the stock in a transaction on Friday, March 2nd. The stock was sold at an average price of $39.25, for a total value of $755,366.25. Following the completion of the transaction, the senior vice president now owns 16,700 shares in the company, valued at $655,475. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Mark Hirschhorn sold 100,000 shares of the firm’s stock in a transaction on Wednesday, February 28th. The shares were sold at an average price of $39.60, for a total value of $3,960,000.00. Following the completion of the transaction, the chief financial officer now owns 98,960 shares of the company’s stock, valued at approximately $3,918,816. The disclosure for this sale can be found here. Insiders sold 458,954 shares of company stock valued at $18,737,432 over the last three months. Corporate insiders own 3.95% of the company’s stock.
Teladoc, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc (NYSE:TDOC).
Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.